Medici, Gioele http://orcid.org/0000-0003-2279-6014
Freudenmann, Lena K.
Velz, Julia
Wang, Sophie Shih-Yüng
Kapolou, Konstantina
Paramasivam, Nagarajan
Mühlenbruch, Lena
Kowalewski, Daniel J.
Vasella, Flavio
Bilich, Tatjana
Frey, Beat M.
Dubbelaar, Marissa L.
Patterson, Angelica Brooke
Zeitlberger, Anna Maria
Silginer, Manuela
Roth, Patrick
Weiss, Tobias
Wirsching, Hans-Georg
Krayenbühl, Niklaus
Bozinov, Oliver
Regli, Luca
Rammensee, Hans-Georg
Rushing, Elisabeth Jane
Sahm, Felix
Walz, Juliane S.
Weller, Michael
Neidert, Marian C.
Funding for this research was provided by:
Kanton Zürich (HSM-2)
University of Zurich
Article History
Received: 13 February 2023
Revised: 16 June 2023
Accepted: 17 June 2023
First Online: 27 June 2023
Declarations
:
: LKF and DK are employees and HGR is a shareholder of Immatics Biotechnologies GmbH. HGR is also shareholder of Curevac SE. MW has received research grants from Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Bayer, Curevac, Medac, Merck (EMD), Novartis, Novocure, Orbus, Philogen, Roche, and Sandoz. PR has received honoraria for lectures or advisory board participation from Alexion, Bristol-Myers Squibb, Boehringer Ingelheim, Debiopharm, Merck Sharp and Dohme, Midatech Pharma, Novocure, and Roche, and research support from Merck Sharp and Dohme and Novocure. TW has received honoraria for consulting or lectures from Phiulogen. KK is an employee of Roche. MCN has received a research grant from Novocure, honoraria for consulting or lectures from WISE, MSD, and Novocure. The other authors declare no competing financial interests.